Speakers at a policy dialogue highlighted the importance of using generic names in prescriptions, a practice common in developed countries and mandated by neighbouring India. They emphasized the need for Bangladesh to adopt similar guidelines to control aggressive drug marketing. Concerns were raised about the current practice of using brand names, which limits competition and increases healthcare costs. Experts stressed holistic healthcare reform and called for a shift towards generic-centric prescriptions to empower consumers and reduce expenses. They noted the potential benefits of lower healthcare costs and informed decision-making. Additionally, they highlighted challenges faced by regulatory authorities in ensuring quality control and uniform pricing due to resource constraints.
Source for more details:
